Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19

Journal of Thrombosis and Thrombolysis(2022)10.1007/s11239-022-02679-5Source: DataRank Database

High levels of von Willebrand factor with reduced specific activities in hospitalized patients with or without COVID-19 is a research paper published in Journal of Thrombosis and Thrombolysis (2022). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (6 grants)Impact (FWCI 0.59)OA: bronzeTopics (25)IDs (PubMed, PMC, OpenAlex)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (6)

Melda A. Guzel,Fong Lam ORCID,Andrew Yee ORCID,Miguel A. Crúz ORCID,Rolando E. Rumbaut ORCID

Live enrichment

PubMed:35881214 PMC:PMC9314532 OpenAlex:https://openalex.org/W4287877345

U.S. Department of Veterans Affairs

Grant: I01 BX002551

National Heart, Lung, and Blood Institute

Grant: HL139425

National Heart, Lung, and Blood Institute

Grant: HL154688

American Society of Hematology

Grant: American Society of Hematology

NHLBI NIH HHS

Grant: T32 HL139425

NHLBI NIH HHS

Grant: R01 HL154688

FWCI

0.59

Citation Percentile

0.7%

Citation Trend

2023

2024

2025

bronzeLicense: https://www.springer.com/tdm

journalhttps://link.springer.com/content/pdf/10.1007/s11239-022-02679-5.pdf

BRONZEhttps://link.springer.com/content/pdf/10.1007/s11239-022-02679-5.pdf

publisherhttps://link.springer.com/content/pdf/10.1007/s11239-022-02679-5.pdf

publisherhttps://link.springer.com/article/10.1007/s11239-022-02679-5/fulltext.html

journalhttps://doi.org/10.1007/s11239-022-02679-5

Fields of Study

Platelet Disorders and TreatmentsBlood groups and transfusionDermatological and COVID-19 studiesMedicine

MeSH Terms

COVID-19CollagenHumansInflammationvon Willebrand Factorvon Willebrand DiseasesPlatelet Glycoprotein GPIb-IX ComplexPandemics

Keywords

Von Willebrand factorMedicineImmunologyCoronavirus disease 2019 (COVID-19)AntigenInternal medicinePlateletInflammationRistocetinDiseaseCollagen BindingCovid-19Glycoprotein Ibm

Sustainable Development Goals

SDG 0: Good health and well-being